Literature DB >> 15324601

Diagnosis, risk factors, and treatment of vascular dementia.

Oscar L Lopez1, Lewis H Kuller, James T Becker.   

Abstract

Although the introduction of modern neuroimaging techniques and standardized clinical evaluations has improved the identification of cerebrovascular disease, the clinical diagnosis of vascular dementia (VaD) is still problematic. Neuropathologic studies have found the current clinical criteria for VaD had low sensitivity with high specificity, suggesting that cerebrovascular disease of sufficient severity to cause cognitive deficits is frequently associated with other disease processes (eg, Alzheimer's disease). The critical factors about the diagnosis of VaD are centered on two issues: definition of dementia and determination of vascular disease. The current clinical criteria for VaD have different definitions of dementia, which are mainly based on an Alzheimer's disease-like presentation, and severe vascular disease can present with or without history of clinical strokes. Therefore, there is a need for a better definition of VaD. This is extremely important to better understand its risk factors, as well as to create homogenous cohorts suitable for drug trials.

Entities:  

Mesh:

Year:  2004        PMID: 15324601     DOI: 10.1007/s11910-004-0082-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  83 in total

1.  The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.

Authors:  L Pantoni; C Bianchi; M Beneke; D Inzitari; A Wallin; T Erkinjuntti
Journal:  J Neurol Sci       Date:  2000-04-15       Impact factor: 3.181

2.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

Authors:  P L Le Bars; M M Katz; N Berman; T M Itil; A M Freedman; A F Schatzberg
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

3.  Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.

Authors:  H Agüero-Torres; L Fratiglioni; Z Guo; M Viitanen; B Winblad
Journal:  J Am Geriatr Soc       Date:  1998-04       Impact factor: 5.562

4.  Increased prevalence of vascular dementia in Japan: a community-based epidemiological study.

Authors:  M Ikeda; K Hokoishi; N Maki; A Nebu; N Tachibana; K Komori; K Shigenobu; R Fukuhara; H Tanabe
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

5.  Poststroke dementia: incidence and relationship to prestroke cognitive decline.

Authors:  H Hénon; I Durieu; D Guerouaou; F Lebert; F Pasquier; D Leys
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

6.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

7.  Frequency and clinical determinants of dementia after ischemic stroke.

Authors:  D W Desmond; J T Moroney; M C Paik; M Sano; J P Mohr; S Aboumatar; C L Tseng; S Chan; J B Williams; R H Remien; W A Hauser; Y Stern
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

8.  Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, placebo-controlled study.

Authors:  G Maina; L Fiori; R Torta; M B Fagiani; L Ravizza; E Bonavita; B Ghiazza; F Teruzzi; P G Zagnoni; E Ferrario
Journal:  Neuropsychobiology       Date:  1989       Impact factor: 2.328

9.  Delayed poststroke dementia: a 4-year follow-up study.

Authors:  M Altieri; V Di Piero; M Pasquini; M Gasparini; N Vanacore; E Vicenzini; G L Lenzi
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

10.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study.

Authors:  T Yoshitake; Y Kiyohara; I Kato; T Ohmura; H Iwamoto; K Nakayama; S Ohmori; K Nomiyama; H Kawano; K Ueda
Journal:  Neurology       Date:  1995-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.